Scientists take early step to personalized breast cancer care

by UT Southwestern Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainUTSouthwestern Medical Center researchers have developed a

Updated on: March 01,2024

Scientists take early step to personalized breast cancer care

by UT Southwestern Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainUTSouthwestern Medical Center researchers have developed a

Updated on:March 01,2024

Salmonella research unlocks the potential of bacteria to treat bowel cancer

byUniversity of GlasgowTILs from mice treated with Salmonella are functionally defective. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-024-00159-2Fighting bowel cancer w

Updated on: December 01,2024

Salmonella research unlocks the potential of bacteria to treat bowel cancer

byUniversity of GlasgowTILs from mice treated with Salmonella are functionally defective. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-024-00159-2Fighting bowel cancer w

Updated on:December 01,2024

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on: December 28,2023

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on:December 28,2023

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on: January 16,2024

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on:January 16,2024

First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb

Updated on: September 30,2024

First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb

Updated on:September 30,2024

Pill halves risk of death in type of lung cancer

Credit: Pixabay/CC0 Public DomainA pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial res

Updated on: February 03,2024

Pill halves risk of death in type of lung cancer

Credit: Pixabay/CC0 Public DomainA pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial res

Updated on:February 03,2024

Deadly 'two-faced' protein drives cancer growth, cripples T-cell avengers

by Delthia Ricks , Medical XpressScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDScientists have deciphered a key st

Updated on: April 09,2024

Deadly 'two-faced' protein drives cancer growth, cripples T-cell avengers

by Delthia Ricks , Medical XpressScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDScientists have deciphered a key st

Updated on:April 09,2024

Novel, non-invasive method to predict and reduce the relapse of childhood cancers

by National University of SingaporeNeuroblastoma CTCs expressing characteristic markers are isolated using cell size-based separation. (A) Schema of experimental design and 3 serial timepoints wh

Updated on: February 03,2024

Novel, non-invasive method to predict and reduce the relapse of childhood cancers

by National University of SingaporeNeuroblastoma CTCs expressing characteristic markers are isolated using cell size-based separation. (A) Schema of experimental design and 3 serial timepoints wh

Updated on:February 03,2024

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on: April 07,2024

Redefining colorectal cancer subtypes

by The City University of New YorkCredit: The City University of New YorkThere is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each ye

Updated on:April 07,2024

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Updated on: March 01,2024

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Updated on:March 01,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on: January 30,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on:January 30,2024

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on: September 07,2024

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on:September 07,2024